{"cik":1990550,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"Ambrx Biopharma, Inc.","units":{"USD":[{"end":"2022-12-31","val":10968000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2022Q4I"},{"end":"2023-09-30","val":9569000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2023Q3I"}]}}